DOI QR코드

DOI QR Code

Saudi Experts Consensus on Diagnosis and Management of Pediatric Functional Constipation

  • Alshehri, Dhafer B. (Department of Pediatrics, Faculty of Medicine, Najran University) ;
  • Sindi, Haifa Hasan (Royal Commission Medical Center) ;
  • AlMusalami, Ibrahim Mohamod (Pediatric Department, Maternity and Children's Hospital) ;
  • Rozi, Ibrahim Hosamuddin (Department of Pediatrics, King Fahd Armed Forces Hospital) ;
  • Shagrani, Mohamed (King Faisal Specialist Hospital and Research Centre, Pediatric Gastroenterology) ;
  • Kamal, Naglaa M. (Pediatric Department, Kasr Alainy Faculty of Medicine, Cairo University) ;
  • Alahmadi, Najat Saeid (Pediatric Department, King Salman Medical City, Ministry of Health) ;
  • Alfuraikh, Samia Saud (King Abdul Aziz Hospital, Ministry of National Guard Health Affairs) ;
  • Vandenplas, Yvan (Vrije Universiteit Brussel, UZ Brussel, KidZ Health Castle)
  • Received : 2021.09.16
  • Accepted : 2022.03.07
  • Published : 2022.05.15

Abstract

Although functional gastrointestinal disorders (FGIDs) are very common in pediatric patients, there is a scarcity of published epidemiologic data, characteristics, and management patterns from Saudi Arabia, which is the 2nd largest Arabic country in terms of area and the 6th largest Arabic country in terms of population, with 10% of its population aged <5 years. Functional constipation (FC) is an FGID that has shown a rising prevalence among Saudi infants and children in the last few years, which urges us to update our clinical practices. Nine pediatric consultants attended two advisory board meetings to discuss and address current challenges, provide solutions, and reach a Saudi national consensus for the management of pediatric constipation. The pediatric consultants agreed that pediatricians should pay attention to any alarming signs (red flags) found during history taking or physical examinations. They also agreed that the Rome IV criteria are the gold standard for the diagnosis of pediatric FC. Different therapeutic options are available for pediatric patients with FC. Dietary treatment is recommended for infants with constipation for up to six months of age. When non-pharmacological interventions fail to improve FC symptoms, pharmacological treatment with laxatives is indicated. First, the treatment is aimed at disimpaction to remove fecal masses. This is achieved by administering a high dose of oral polyethylene glycol (PEG) or lactulose for a few days. Subsequently, maintenance therapy with PEG should be initiated to prevent the re-accumulation of feces. In addition to PEG, several other options may be used, such as Mg-rich formulas or stimulant laxatives. However, rectal enemas and suppositories are usually reserved for cases that require acute pain relief. In contrast, infant formulas that contain prebiotics or probiotics have not been shown to be effective in infant constipation, while the use of partially hydrolyzed formula is inconclusive. These clinical practice recommendations are intended to be adopted by pediatricians and primary care physicians across Saudi Arabia.

Keywords

Acknowledgement

The consensus panel experts would like to thank Novalac Middle East for their organization and support of the Working Group, which facilitated the process of consensus manuscript development. We would also like to thank Dr. Ahmed Salah Hussein M.D of RAY-CRO for his editorial support in drafting and writing consensus statements.

References

  1. Sepanlou SG, Malekzadeh F, Delavari F, Naghavi M, Forouzanfar MH, Moradi-Lakeh M, et al. Burden of gastrointestinal and liver diseases in Middle East and North Africa: results of Global Burden of Diseases Study from 1990 to 2010. Middle East J Dig Dis 2015;7:201-15.
  2. Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004;18:613-31. https://doi.org/10.1016/j.bpg.2004.04.012
  3. Berens S, Engel F, Gauss A, Tesarz J, Herzog W, Niesler B, et al. Patients with multiple functional gastrointestinal disorders (FGIDs) show increased illness severity: a cross-sectional study in a tertiary care FGID specialty clinic. Gastroenterol Res Pract 2020;2020:9086340.
  4. Chogle A, Velasco-Benitez CA, Koppen IJ, Moreno JE, Ramirez Hernandez CR, Saps M. A population-based study on the epidemiology of functional gastrointestinal disorders in young children. J Pediatr 2016;179:139-43.e1. https://doi.org/10.1016/j.jpeds.2016.08.095
  5. Zeevenhooven J, Koppen IJ, Benninga MA. The new Rome IV criteria for functional gastrointestinal disorders in infants and toddlers. Pediatr Gastroenterol Hepatol Nutr 2017;20:1-13. https://doi.org/10.5223/pghn.2017.20.1.1
  6. Diaz S, Bittar K, Mendez MD. Constipation. In: Abai B, Abu-Ghosh A, Acharya AB, Acharya U, Adhia SG, Aeby TC, et al., eds. StatPearls. Treasure Island: StatPearls Publishing, 2021.
  7. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014;58:258-74. https://doi.org/10.1097/MPG.0000000000000266
  8. Sparberg M. Constipation. In: Walker HK, Hall WD, Hurst JW, eds. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths, 1990.
  9. Xinias I, Mavroudi A. Constipation in childhood. An update on evaluation and management. Hippokratia 2015;19:11-9.
  10. Steutel NF, Zeevenhooven J, Scarpato E, Vandenplas Y, Tabbers MM, Staiano A, et al. Prevalence of functional gastrointestinal disorders in European infants and toddlers. J Pediatr 2020;221:107-14. https://doi.org/10.1016/j.jpeds.2020.02.076
  11. Fujitani A, Sogo T, Inui A, Kawakubo K. Prevalence of functional constipation and relationship with dietary habits in 3- to 8-year-old children in Japan. Gastroenterol Res Pract 2018;2018:3108021.
  12. Bellaiche M, Ategbo S, Krumholz F, Ludwig T, Miqdady M, Abkari A, et al. A large-scale study to describe the prevalence, characteristics and management of functional gastrointestinal disorders in African infants. Acta Paediatr 2020;109:2366-73. https://doi.org/10.1111/apa.15248
  13. Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2016;150:1443-55.e2. https://doi.org/10.1053/j.gastro.2016.02.016
  14. Whitfield KL, Shulman RJ. Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches. Pediatr Ann 2009;38:288-90, 292-4.
  15. Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984;74:979-83. https://doi.org/10.2105/AJPH.74.9.979
  16. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. https://doi.org/10.1136/bmj.39489.470347.ad
  17. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016;150:1262-79.e2.
  18. Vandenplas Y, Alturaiki MA, Al-Qabandi W, AlRefaee F, Bassil Z, Eid B, et al. Middle East consensus statement on the diagnosis and management of functional gastrointestinal disorders in <12 months old infants. Pediatr Gastroenterol Hepatol Nutr 2016;19:153-61. Erratum in: Pediatr Gastroenterol Hepatol Nutr 2016;19:291-2. https://doi.org/10.5223/pghn.2016.19.3.153
  19. Loening-Baucke V, Kimura K. Failure to pass meconium: diagnosing neonatal intestinal obstruction. Am Fam Physician 1999;60:2043-50.
  20. Mazurek MO, Vasa RA, Kalb LG, Kanne SM, Rosenberg D, Keefer A, et al. Anxiety, sensory overresponsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol 2013;41:165-76. https://doi.org/10.1007/s10802-012-9668-x
  21. Samsam M, Ahangari R, Naser SA. Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol 2014;20:9942-51. https://doi.org/10.3748/wjg.v20.i29.9942
  22. Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol 2011;25:3-18. https://doi.org/10.1016/j.bpg.2010.12.010
  23. Lewis ML, Palsson OS, Whitehead WE, van Tilburg MAL. Prevalence of functional gastrointestinal disorders in children and adolescents. J Pediatr 2016;177:39-43.e3.
  24. Saps M, Nichols-Vinueza DX, Rosen JM, Velasco-Benitez CA. Prevalence of functional gastrointestinal disorders in Colombian school children. J Pediatr 2014;164:542-5.e1.
  25. Huang Y, Tan SY, Parikh P, Buthmanaban V, Rajindrajith S, Benninga MA. Prevalence of functional gastrointestinal disorders in infants and young children in China. BMC Pediatr 2021;21:131. https://doi.org/10.1186/s12887-021-02610-6
  26. Walter HAW, Hovenkamp A, Rajindrajith S, Devanarayana NM, Rajapakshe NN, Benninga MA. OP-12 prevalence of functional constipation in infants and toddlers in Sri Lanka. J Pediatr Gastroenterol Nutr 2015;61:514.
  27. Bhatia V, Deswal S, Seth S, Kapoor A, Sibal A, Gopalan S. Prevalence of functional gastrointestinal disorders among adolescents in Delhi based on Rome III criteria: a school-based survey. Indian J Gastroenterol 2016;35:294-8. https://doi.org/10.1007/s12664-016-0680-x
  28. Hasosah M, Alsahafi A, Alghraibi A, Alqarni N, Babatin A, Matrafi A, et al. Prevalence, characterization and risk factors of chronic constipation among Saudi children: a cross-sectional study. Int J Adv Res (Indore) 2018;6:1319-24. https://doi.org/10.21474/ijar01/6986
  29. Ibrahim ATA, Hamdy AM, Elhodhod MA. Prevalence of functional gastrointestinal disorders among school-aged children and adolescents, a multicenter study. QJM 2020;113 Suppl 1:hcaa063.029. https://doi.org/10.1093/qjmed/hcaa063.029
  30. van Tilburg MA, Hyman PE, Walker L, Rouster A, Palsson OS, Kim SM, et al. Prevalence of functional gastrointestinal disorders in infants and toddlers. J Pediatr 2015;166:684-9. https://doi.org/10.1016/j.jpeds.2014.11.039
  31. Kramer EA, den Hertog-Kuijl JH, van den Broek LM, van Leengoed E, Bulk AM, Kneepkens CM, et al. Defecation patterns in infants: a prospective cohort study. Arch Dis Child 2015;100:533-6. https://doi.org/10.1136/archdischild-2014-307448
  32. Hill DJ, Firer MA, Shelton MJ, Hosking CS. Manifestations of milk allergy in infancy: clinical and immunologic findings. J Pediatr 1986;109:270-6. https://doi.org/10.1016/S0022-3476(86)80384-5
  33. Bahna SL. Cow's milk allergy versus cow milk intolerance. Ann Allergy Asthma Immunol 2002;89(6 Suppl 1):56-60. https://doi.org/10.1016/S1081-1206(10)62124-2
  34. Yang QH, Zheng BS, Zhou SM, Dai DL. [Clinical features of cow's milk protein allergy in infants presenting mainly with gastrointestinal symptoms: an analysis of 280 cases]. Zhongguo Dang Dai Er Ke Za Zhi 2019;21:271-6. Chinese.
  35. Vandenplas Y, Koletzko S, Isolauri E, Hill D, Oranje AP, Brueton M, et al. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child 2007;92:902-8. Erratum in: Arch Dis Child 2007;92:following 908. Erratum in: Arch Dis Child 2008;93:93. https://doi.org/10.1136/adc.2006.110999
  36. Iacono G, Cavataio F, Montalto G, Florena A, Tumminello M, Soresi M, et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med 1998;339:1100-4. https://doi.org/10.1056/NEJM199810153391602
  37. van Ginkel R, Reitsma JB, Buller HA, van Wijk MP, Taminiau JA, Benninga MA. Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 2003;125:357-63. https://doi.org/10.1016/S0016-5085(03)00888-6
  38. Iacono G, Carroccio A, Cavataio F, Montalto G, Cantarero MD, Notarbartolo A. Chronic constipation as a symptom of cow milk allergy. J Pediatr 1995;126:34-9. https://doi.org/10.1016/S0022-3476(95)70496-5
  39. Carroccio A, Montalto G, Custro N, Notarbartolo A, Cavataio F, D'Amico D, et al. Evidence of very delayed clinical reactions to cow's milk in cow's milk-intolerant patients. Allergy 2000;55:574-9. https://doi.org/10.1034/j.1398-9995.2000.00417.x
  40. Kamer B, Dolka E, Pyziak K, Blomberg A. [Food allergy as a cause of constipation in children in the first three years of life - own observations]. Med Wieku Rozwoj 2011;15:157-61. Polish.
  41. Meyer R, Chebar Lozinsky A, Fleischer DM, Vieira MC, Du Toit G, Vandenplas Y, et al. Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-an EAACI Position Paper. Allergy 2020;75:14-32. https://doi.org/10.1111/all.13947
  42. Read NW, Miles CA, Fisher D, Holgate AM, Kime ND, Mitchell MA, et al. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology 1980;79:1276-82. https://doi.org/10.1016/0016-5085(80)90925-7
  43. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920-4. https://doi.org/10.3109/00365529709011203
  44. Bekkali N, Hamers SL, Reitsma JB, Van Toledo L, Benninga MA. Infant stool form scale: development and results. J Pediatr 2009;154:521-6.e1.
  45. Huysentruyt K, Koppen I, Benninga M, Cattaert T, Cheng J, De Geyter C, et al. The Brussels Infant and Toddler Stool Scale: a study on interobserver reliability. J Pediatr Gastroenterol Nutr 2019;68:207-13. https://doi.org/10.1097/MPG.0000000000002153
  46. Velasco-Benitez CA, Llanos-Chea A, Saps M. Utility of the Brussels Infant and Toddler Stool Scale (BITSS) and Bristol Stool Scale in non-toilet-trained children: a large comparative study. Neurogastroenterol Motil 2021;33:e14015.
  47. Bongers ME, de Lorijn F, Reitsma JB, Groeneweg M, Taminiau JA, Benninga MA. The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial. Nutr J 2007;6:8. https://doi.org/10.1186/1475-2891-6-8
  48. Quinlan PT, Lockton S, Irwin J, Lucas AL. The relationship between stool hardness and stool composition in breast- and formula-fed infants. J Pediatr Gastroenterol Nutr 1995;20:81-90. https://doi.org/10.1097/00005176-199501000-00014
  49. Wood HC. Therapeutics: its principles and practice. 11th ed. Philadelphia: J.B. Lippincott, 1900.
  50. Izzo AA, Gaginella TS, Capasso F. The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res 1996;9:133-8.
  51. Dupont C, Campagne A, Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol 2014;12:1280-7. https://doi.org/10.1016/j.cgh.2013.12.005
  52. Dupont C, Constant F, Imbert A, Hebert G, Zourabichvili O, Kapel N. Time to treatment response of a magnesium- and sulphate-rich natural mineral water in functional constipation. Nutrition 2019;65:167-72. https://doi.org/10.1016/j.nut.2019.02.018
  53. Naumann J, Sadaghiani C, Alt F, Huber R. Effects of sulfate-rich mineral water on functional constipation: a double-blind, randomized, placebo-controlled study. Forsch Komplement Med 2016;23:356-63.
  54. Bothe G, Coh A, Auinger A. Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study. Eur J Nutr 2017;56:491-9. https://doi.org/10.1007/s00394-015-1094-8
  55. Chao HC, Vandenplas Y. Therapeutic effect of Novalac-IT in infants with constipation. Nutrition 2007;23:469-73. https://doi.org/10.1016/j.nut.2007.03.006
  56. Benninga MA; MENA Infant Constipation Study Group. Vandenplas Y. The magnesium-rich formula for functional constipation in infants: a randomized comparator-controlled study. Pediatr Gastroenterol Hepatol Nutr 2019;22:270-81. https://doi.org/10.5223/pghn.2019.22.3.270
  57. Xinias I, Analitis A, Mavroudi A, Roilides I, Lykogeorgou M, Delivoria V, et al. A synbiotic infant formula with high magnesium content improves constipation and quality of life. Pediatr Gastroenterol Hepatol Nutr 2018;21:28-33. https://doi.org/10.5223/pghn.2018.21.1.28
  58. Boateng L, Ansong R, Owusu WB, Steiner-Asiedu M. Coconut oil and palm oil's role in nutrition, health and national development: a review. Ghana Med J 2016;50:189-96. https://doi.org/10.4314/gmj.v50i3.11
  59. Bronsky J, Campoy C, Embleton N, Fewtrell M, Mis NF, Gerasimidis K, et al. Palm oil and beta-palmitate in infant formula: a position paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. J Pediatr Gastroenterol Nutr 2019;68:742-60. https://doi.org/10.1097/mpg.0000000000002307
  60. Mancini A, Imperlini E, Nigro E, Montagnese C, Daniele A, Orru S, et al. Biological and nutritional properties of palm oil and palmitic acid: effects on health. Molecules 2015;20:17339-61. https://doi.org/10.3390/molecules200917339
  61. Alarcon PA, Tressler RL, Mulvaney A, Lam W, Comer GM. Gastrointestinal tolerance of a new infant milk formula in healthy babies: an international study conducted in 17 countries. Nutrition 2002;18:484-9. https://doi.org/10.1016/S0899-9007(02)00752-9
  62. Lloyd B, Halter RJ, Kuchan MJ, Baggs GE, Ryan AS, Masor ML. Formula tolerance in postbreastfed and exclusively formula-fed infants. Pediatrics 1999;103:E7. https://doi.org/10.1542/peds.103.1.e7
  63. Lasekan JB, Hustead DS, Masor M, Murray R. Impact of palm olein in infant formulas on stool consistency and frequency: a meta-analysis of randomized clinical trials. Food Nutr Res 2017;61:1330104. https://doi.org/10.1080/16546628.2017.1330104
  64. Hyams JS, Treem WR, Etienne NL, Weinerman H, MacGilpin D, Hine P, et al. Effect of infant formula on stool characteristics of young infants. Pediatrics 1995;95:50-4. https://doi.org/10.1542/peds.95.1.50
  65. Savino F, Cresi F, Maccario S, Cavallo F, Dalmasso P, Fanaro S, et al. "Minor" feeding problems during the first months of life: effect of a partially hydrolysed milk formula containing fructo- and galactooligosaccharides. Acta Paediatr Suppl 2003;91:86-90.
  66. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012;3:4-14. https://doi.org/10.4161/gmic.19320
  67. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota's effect on mental health: the gut-brain axis. Clin Pract 2017;7:987. https://doi.org/10.4081/cp.2017.987
  68. Davis CD. The gut microbiome and its role in obesity. Nutr Today 2016;51:167-74. https://doi.org/10.1097/NT.0000000000000167
  69. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14. https://doi.org/10.1038/nrgastro.2014.66
  70. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 2019;8:92. https://doi.org/10.3390/foods8030092
  71. Ashley C, Johnston WH, Harris CL, Stolz SI, Wampler JL, Berseth CL. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J 2012;11:38. https://doi.org/10.1186/1475-2891-11-38
  72. Skorka A, Piescik-Lech M, Kolodziej M, Szajewska H. To add or not to add probiotics to infant formulae? An updated systematic review. Benef Microbes 2017;8:717-25. https://doi.org/10.3920/BM2016.0233
  73. Gonzalez-Bermudez CA, Lopez-Nicolas R, Peso-Echarri P, Frontela-Saseta C, Martinez-Gracia C. Effects of different thickening agents on infant gut microbiota. Food Funct 2018;9:1768-78. https://doi.org/10.1039/C7FO01992K
  74. Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev 2016;2016:CD009118.
  75. Dupont C, Hebert G. Magnesium sulfate-rich natural mineral waters in the treatment of functional constipation-a review. Nutrients 2020;12:2052. https://doi.org/10.3390/nu12072052
  76. Guest JF, Candy DC, Clegg JP, Edwards D, Helter MT, Dale AK, et al. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales. Curr Med Res Opin 2007;23:2213-25. Erratum in: Curr Med Res Opin 2020;36:527. https://doi.org/10.1185/030079907X210462
  77. Tannock GW, Lawley B, Munro K, Gowri Pathmanathan S, Zhou SJ, Makrides M, et al. Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk. Appl Environ Microbiol 2013;79:3040-8. https://doi.org/10.1128/AEM.03910-12
  78. Infante DD, Prosser CG, Tormo R. Constipated patients fed goat milk protein formula: a case series study. J Nutr Health Sci 2018;5:203.
  79. Tounian P, Meunier L, Speijers G, Oozeer R, Vandenplas Y. Effectiveness and tolerance of a locust bean gum-thickened formula: a real-life study. Pediatr Gastroenterol Hepatol Nutr 2020;23:511-20. https://doi.org/10.5223/pghn.2020.23.6.511
  80. Salvatore S, Savino F, Singendonk M, Tabbers M, Benninga MA, Staiano A, et al. Thickened infant formula: what to know. Nutrition 2018;49:51-6. https://doi.org/10.1016/j.nut.2017.10.010